Evaluation of Galectin-3 as a Novel Biomarker for Chagas Cardiomyopathy

By  

Cardiology, Vol. 136, Iss. 1, 2016-08 ,pp. : 33-39

Karger

Access to resources Recommend Favorite

Prognostic Significance of Circulating Levels of Hepatocyte Growth Factor in Patients with Chagas’ Disease and Idiopathic Dilated Cardiomyopathy

By  

Cardiology, Vol. 121, Iss. 4, 2012-05 ,pp. : 240-246

Karger

Access to resources Recommend Favorite

Detection of Trypanosoma cruziDNA in blood by PCR is associated with Chagas cardiomyopathy and disease severity

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 4, 2015-04 ,pp. : 416-423

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chagas cardiomyopathy and serologic testing in a small rural hospital in Chiapas, Mexico [Miocardiopatía chagásica y pruebas serológicas de enfermedad de Chagas en un hospital rural pequeño de Chiapas, México]

By Capps Linnea   Abad Begoña  

Revista Panamericana de Salud Pública/Pan American Journal of Public Health, Vol. 15, Iss. 5, 2004-05 ,pp. : 337-340

Pan American Health Organization (PAHO)

Access to resources Recommend Favorite

Serological screening of Chagas disease in an immigrant population in Asturias, Spain proceeding from Chagas-endemic areas

By Rodriguez-Guardado Azucena   Rodriguez Mercedes   Alonso Paula   Seco Carolina   Flores-Chavez Maria   Mejuto Patricia   Carton Jose  

Scandinavian Journal of Infectious Diseases, Vol. 41, Iss. 10, 2009-01 ,pp. : 774-776

Informa Healthcare

Access to resources Recommend Favorite